当前位置:药药网 / 数据中心 / 生物制药海外临床研究状况
Sabatolimab as a Treatment for Patients With Acute Myeloid Leukemia and Presence of Measurable Residual Disease After Allogeneic Stem Cell Transplantation.
标题(英文)
Sabatolimab as a Treatment for Patients With Acute Myeloid Leukemia and Presence of Measurable Residual Disease After Allogeneic Stem Cell Transplantation.
条件
Acute Myeloid Leukemia
干预
Biological: Sabatolimab|Drug: Azacitidine